News Releases

11 Jul '24
REYKJAVIK, Iceland, July 11, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing of its previously announced senior secured first lien term loan
03 Jul '24
Attached is a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons. Attachment Managers Transaction CSSF Form - ATP Holdings ehf 20240702
03 Jul '24
Attached is a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding a "notification of major holdings" in Alvotech by Aztiq Pharma Partners S.a r.l. and ATP Holdings ehf. On July 1, 2024 the shareholder acquired 2,587,089 additional ordinary shares in Alvotech
01 Jul '24
REYKJAVIK, Iceland, July 01, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued new shares to holders of subordinated convertible bonds, originally issued by Alvotech
26 Jun '24
Attached is a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding a manager's transaction, related to the acquisition shares upon the exercise of stock options.  Attachment Alvotech - Managers' Transaction Notification Richard Davies 20240626
Displaying 1 - 10 of 172